Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

P-glycoprotein activity and biological response.

W Vaalburg1, N H Hendrikse, P H Elsinga

  • 1Groningen University Hospital, PO Box 30.001, 9700 RB Groningen, The Netherlands. w.vaalburg@pet.umcg.nl

Toxicology and Applied Pharmacology
|July 27, 2005
PubMed
Summary

P-glycoprotein (P-gp) is a key drug efflux pump contributing to multidrug resistance (MDR) in tumors. Positron emission tomography (PET) can visualize P-gp function and assess drug resistance modulation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of pre-analytical factors on the success rates of smMIP and MLPA analyses in epithelial ovarian cancer.

Virchows Archiv : an international journal of pathology·2025
Same author

Bacteria-targeted imaging using vancomycin-based positron emission tomography tracers can distinguish infection from sterile inflammation.

European journal of nuclear medicine and molecular imaging·2024
Same author

Does serous tubal intraepithelial carcinoma (STIC) metastasize? The clonal relationship between STIC and subsequent high-grade serous carcinoma in BRCA1/2 mutation carriers several years after risk-reducing salpingo-oophorectomy.

Gynecologic oncology·2024
Same author

Synthesis and preclinical evaluation of novel <sup>18</sup>F-vancomycin-based tracers for the detection of bacterial infections using positron emission tomography.

European journal of nuclear medicine and molecular imaging·2024
Same author

Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer.

ESMO open·2024
Same author

Caloric restriction reduces proteinuria in male rats with established nephropathy.

Physiological reports·2024

Area of Science:

  • Pharmacology and Molecular Biology
  • Oncology
  • Radiochemistry

Background:

  • P-glycoprotein (P-gp), encoded by the MDR-1 gene, acts as a transmembrane drug efflux pump, protecting organs from toxins.
  • P-gp expression in the blood-brain barrier affects drug distribution, and its role in multidrug resistance (MDR) is extensively studied.
  • Tumor MDR, characterized by resistance to multiple chemotherapeutics, can be mediated by P-gp's extrusion of drugs from cancer cells.

Purpose of the Study:

  • To investigate P-glycoprotein (P-gp) functionality and its impact on drug pharmacokinetics using in vivo imaging.
  • To evaluate the efficacy of P-gp modulators in altering drug bioavailability and overcoming multidrug resistance (MDR).
  • To explore the potential of positron emission tomography (PET) in assessing P-gp's role in drug resistance and response to modulators.

Related Experiment Videos

Main Methods:

  • Utilized positron emission tomography (PET) with carbon-11 and fluorine-18 labeled P-gp substrates and modulators for in vivo studies.
  • Investigated the effect of P-gp modulators, including verapamil, cyclosporin A, ONT-093, and XR9576, on P-gp functionality.
  • Assessed drug pharmacokinetics and bioavailability in humans in vivo by measuring tissue concentrations using PET.

Main Results:

  • PET imaging demonstrated the ability to study P-gp functionality and its impact on drug pharmacokinetics in vivo.
  • The study showed that P-gp modulators can alter drug bioavailability, suggesting potential for overcoming drug resistance.
  • PET allows for the in vivo measurement of the efficacy of novel P-gp modulators in human subjects.

Conclusions:

  • Positron emission tomography (PET) is a valuable tool for studying P-glycoprotein (P-gp) function and drug pharmacokinetics in vivo.
  • P-gp modulation holds promise for enhancing chemotherapy efficacy by increasing intracellular drug concentrations in tumors.
  • PET imaging can guide the development and clinical application of P-gp modulators for cancer treatment.